<DOC>
	<DOCNO>NCT00595543</DOCNO>
	<brief_summary>To compare bromfenac 0.09 % , diclofenac sodium 0.1 % , ketorolac tromethamine 0.5 % ophthalmic solution treatment acute pseudophakic CME cataract surgery .</brief_summary>
	<brief_title>Treatment Acute Pseudophakic Cystoid Macular Edema : Bromfenac 0.09 % Versus Diclofenac Sodium 0.1 % Versus Ketorolac Tromethamine 0.5 %</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<criteria>Patients must diagnose acute pseudophakic CME within 12 month cataract surgery Males females 18 year older Able provide write informed consent Complicated cataract surgery , particularly posterior capsule rupture vitreous loss PreExisting macular pathology , include macular edema , macular scar , macular hole , macular pucker History Uveitis Ipsilateral intraocular surgery prior cataract surgery CME great one year duration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>